| (19) |
 |
|
(11) |
EP 0 064 869 B1 |
| (12) |
EUROPEAN PATENT SPECIFICATION |
| (45) |
Mention of the grant of the patent: |
|
22.01.1986 Bulletin 1986/04 |
| (22) |
Date of filing: 07.05.1982 |
|
| (51) |
International Patent Classification (IPC)4: C07D 307/52 // C07C149/437 |
|
| (54) |
Process for the preparation of a furan derivative
Verfahren zur Herstellung von Furanderivaten
Procédé pour la préparation de dérivés du furanne
|
| (84) |
Designated Contracting States: |
|
AT BE CH DE FR GB IT LI LU NL SE |
| (30) |
Priority: |
07.05.1981 GB 8113944
|
| (43) |
Date of publication of application: |
|
17.11.1982 Bulletin 1982/46 |
| (71) |
Applicant: GLAXO GROUP LIMITED |
|
Greenford, Middlesex UB6 ONN (GB) |
|
| (72) |
Inventor: |
|
- Clitherow, John Watson
Sawbridsgeworth
Hertfordshire (GB)
|
| (74) |
Representative: Marchant, James Ian et al |
|
Elkington and Fife,
Prospect House,
8 Pembroke Road Sevenoaks,
Kent TN13 1XR Sevenoaks,
Kent TN13 1XR (GB) |
|
| |
|
| Note: Within nine months from the publication of the mention of the grant of the European
patent, any person may give notice to the European Patent Office of opposition to
the European patent
granted. Notice of opposition shall be filed in a written reasoned statement. It shall
not be deemed to
have been filed until the opposition fee has been paid. (Art. 99(1) European Patent
Convention).
|
[0001] This invention relates to a process for the preparation of a furan derivative.
[0002] The furan derivative of formula (I)

which is known as ranitidine is disclosed in British Patent Specification No. 1565966
as a potent and selective H
2-antagonist.
[0003] The present invention provides a process for the preparation of ranitidine of formula
(I) which comprises reacting cystamine of formula (II)

either with a nitroethenamine of formula (III)

where L is alkylthio, e.g. methylthio, or with a compound of formula (IV)

where L is as defined above, followed by reaction with methylamine, to give a disulphide
of formula (V)

which is then reacted with 5-[(dimethylamino)methyl]-2-furanmethanol.
[0004] The reaction of the disulphide (V) with 5-[(dimethylamino)methyl]-2-furanmethanol
is carried out under acid conditions and conveniently at a temperature within the
range 0-100°C. Suitable acids include mineral acids such as hydrochloric or sulphuric
acid, hydrochloric acid being preferred. More preferably the reaction is carried out
in the presence of concentrated hydrochloric acid, conveniently at an initial temperature
of 04°C with subsequent heating for a short period at for example 90―100°C. Alternatively
the reaction may be carried out in the presence of aqueous acid e.g. 5M hydrochloric
acid or 5N sulphuric acid, preferably with heating e.g. at a temperature in the range
of 35-50°C.
[0005] In the preparation of the intermediate disulphide (V) cystamine is preferably reacted
with the nitroethenamine of formula (III). This reaction may be carried out in the
presence of a solvent such as acetonitrile or more preferably water, and conveniently
at a temperature within the range of 0° to room temperature. Alternatively cystamine
may be reacted with a compound of formula (IV) under the conditions described above,
followed by reaction with methylamine at a temperature from ambient to reflux, preferably
at room temperature.
[0006] Cystamine may conveniently be generated in situ from a salt such as the dihydrochloride
for example by reaction with a base such as potassium hydroxide.
[0007] It is desirable to pass a steady stream of a gas, such as nitrogen or air, through
the reaction vessel during preparation of the disulphide.
[0008] If desired the furan derivative of formula (I) once obtained may be converted into
an acid addition salt, e.g. a hydrochloride, using conventional methods. Thus for
example appropriate quantities of the free base of formula (I) and an acid, e.g. hydrochloric
acid, may be mixed in a suitable solvent(s), e.g. an alcohol such as ethanol, or an
ester such as ethyl acetate.
[0009] The process of the present invention is advantageous in that it uses cheap and readily
available starting materials, and the intermediate disulphide may be readily isolated
in pure crystalline form.
[0010] The invention is illustrated by the following Examples.
Example 1
N-[2-[[5-[(Dimethylamino)methyl]-2-furanylmethyl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine
(a) N,N'-bis-[Thio(2,1-ethanediyl)]bis(N'-methyl-2-nitro-1,1-ethenediamine)
[0011] To a stirred solution of 2,2'-dithiobisethanamine dihydrochloride (6.75 g) and potassium
hydroxide (3.37 g) in water (150 ml) at 0-4° was added finely powdered N-methyl-(1-methylthio)-2-nitroethenamine
(8.98 g). A rapid stream of air was passed through the ice cold mixture for 2h and
for a further 2h after the mixture had reached room temperature. The white precipitate
which separated was filtered, washed with water than ethanol and ether and dried to
give the title compound (8.53 g), m.p. 205-207° decomp.

(b) N-[2-[[5-[(Dimethylamino)methyl]-2-furanylmethyl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine
[0012] To a solution of 5-[(dimethylamino)methyl]-2-furanmethanol (1.72 g) in 5M hydrochloric
acid (2.2 ml) at room temperature was added N,N'-bis[thio(2,1-ethanediyl)]bis(N'-methyl-2-nitro-1,1-ethenediamine)
(1.76 g) and 5M hydrochloric acid (10 ml). After heating at 40-45°C for 23.5h, tetrahydrofuran
(120 ml) and excess anhydrous sodium carbonate was added. The mixture was stood at
room temperature for 25.5h then filtered and the filtrate evaporated in vacuo to give
an oil (2.8 g). This was chromatographed on silica using methanol- 0.88 ammonia, 200:1
and the appropriate eluate evaporated in vacuo to give an oil (0.37 g). The solid
which separated on crystallisation from 4-methyl-pentan-2-one was filtered, washed
with 4-methylpentan-2-one, isopropyl acetate and ether to give the title compound
(0.09 g), m.p. 67.5-69° which was not depressed on admixture with a sample prepared
according to the method of Example 15 in British Patent Specification No: 1565966.
Example 2
N-[2-[[5-[(Dimethylaminolmethyl]-2-furanylmethyl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine
[0013] To a stirred solution of N,N'-bis[thio(2,1-ethanediyl)]bis(N'-methyl-2-nitro-1,1-ethenediamine)
(1.76 g) in concentrated hydrochloric acid (12 ml) cooled in ice was added 5-[(dimethylamino)methyl]-2-furanmethanol
(1.72 g). The mixture was kept at 0―4° for 64.5 hours and a further quantity of 5-[(dimethylamino)methyl]-2-furanmethanol
(1.4 g) added. The mixture was heated at 98-100° for 15 min. and the solution neutralised
with sodium bicarbonate. Excess of anhydrous sodium carbonate and tetrahydrofuran
(100 ml) were added and after 3 hours, the mixture was filtered and the filtrate evaporated
in vacuo to give a dark oil. This oil was dissolved in 2-methylpentan-2-one (15 ml),
and decolourising charcoal added, before the solution was heated to 98-100° and filtered.
The filtrate was evaporated in vacuo and the oily residue was mixed with water (10
ml) at 60°. The mixture was treated with decolourising charcoal and the solution filtered.
The filtrate was evaporated to dryness in vacuo to give an oil (0.73 g) consisting
of the title compound.
[0014] T.L.C. Silica; methanol:0.88 ammonia (200:1) R
f 0.45 Consistent with a sample prepared according to the method of Example 15 in British
Patent Specification No. 1565966.
1. A process for the preparation of ranitidine of formula (I)

which comprises reacting cystamine of formula (II)

either with a nitroethenamine of formula (III)

where L is alkylthio, or with a compound of formula (IV)

where L is alkylthio, followed by reaction with methylamine, to give a disulphide
of formula (V)

which is then reacted with 5-[(dimethylamino)methyl]-2-furanmethanol under acid conditions.
2. A process as claimed in claim 1 wherein the reaction between the disulphide (V)
and [(dimethylamino)methyl]-2-furanmethanol is carried out at a temperature of 0 to
100°C.
3. A process as claimed in claim 1 or 2 wherein the reaction between the disulphide
(V) and E [(dimethylamino)methyl]-2-furanmethanol is carried out in the presence of
hydrochloric acid.
4. A process as claimed in claim 3 wherein the reaction is carried out in the presence
of concentratel hydrochloric acid at an initial temperature of 0―4.°C, with subsequent heating for
a short period 90-100°C.
5. A process as claimed in any of claims 1 to 4 wherein the disulphide (V) is prepared
by reaction c cystamine and a nitroethenamine of formula (III) and this reaction is
carried out in the presence of a suitabl solvent.
6. A process as claimed in claim 5, wherein the solvent is water.
7. A process as claimed in any of claims 1 to 6 wherein a steady stream of gas is
passed through th reaction vessel during preparation of the disulphide.
8. A process as claimed in any of claims 1 to 7 in which the compound of formula (I)
is converted into a acid addition salt.
9. A process as claimed in claim 8 in which the acid addition salt is the hydrochloride.
1. Verfahren zur Herstellung von Rantinidin der Formel (I)

dadurch gekennzeichnet, daß man Cystamin der Formel (11)

entweder mit Nitroethenamin der Formel (111)

worin L Alkylthio ist, oder einer Verbindung der Formel (IV)

worin L Alkylthio ist, umsetzt und anschließend mit Methylamin umsetzt, um ein Disulfid
der Formel (V)

welches sodann mit 5-[(Dimethylamino)methyl]-2-furanmethanol unter sauren Bedingungen
umgesetzt wird.
2. Verfahren nach Anspruch 1, dadurch gekennzeichnet, daß die Reaktion zwischen dem
Disulfid (V) und dem 5-[(Dimethylamino)methyl]-2-furanmethanol bei einer Temperatur
von 0 bis 100°C durchgeführt wird.
3. Verfahren nach Anspruch 1 oder 2, dadurch gekennzeichnet, daß die Reaktion zwischen
dem Disulfid (V) und dem 5-[(Dimethylamino)methyl]-2-furanmethanol in Gegenwart von
Salzsäure durchgeführt wird.
4. Verfahren nach Anspruch 3, dadurch gekennzeichnet, daß die Reaktion in Gegenwart
von konzentrierter Salzsäure bei einer Anfangstemperatur von 04°C und unter nachfolgendem
Erhitzen über einen kurzen Zeitraum auf 90 bis 100°C durchgeführt wird.
5. Verfahren nach einem der Ansprüche 1 bis 4, dadurch gekennzeichnet, daß das Disulfid
(V) durch Umsetzung von Cystamin und einem Nitroethenamin der Formel (111) hergestellt
wird und daß diese Reaktion in Gegenwart eines geeigneten Lösungsmittels durchgeführt
wird.
6. Verfahren nach Anspruch 5, dadurch gekennzeichnet, daß das Lösungsmittel Wasser
ist.
7. Verfahren nach einem der Ansprüche 1 bis 6, dadurch gekennzeichnet, daß ein stetiger
Strom von Gas durch das Reaktionsgefäß während der Herstellung des Disulfids hindurchgeleitet
wird.
8. Verfahren nach einem der Ansprüche 1 bis 7, dadurch gekennzeichnet, daß die Verbindung
der Formel (I) in ein Säureadditionssalz umgewandelt wird.
9. Verfahren nach Anspruch 8, dadurch gekennzeichnet, daß das Säureadditionssalz das
Hydrochlorid ist.
1. Procédé pour la préparation de ranitidine de formule (1)

qui comprend la réaction de la cystamine de formule (II)

soit avec une nitroéthènamine de formule (III)

dans laquelle L est un groupe alkylthio, ou avec un composé de formule (IV)

dans laquelle L est un groupe alkylthio, suivie de la réaction avec la méthylamine,
pour donner un bisulfure de formule (V)

que l'on fait ensuite réagir avec le 5-[(diméthylamino)méthyl]-2-furanne-méthanol
dans des conditions acides.
2. Procédé selon la revendication 1, dans lequel la réaction entre le bisulfure (V)
et le 5-[(diméthylamino)méthyl]-2-furanne-méthanol est réalisée à une température
de 0 à 100°C.
3. Procédé selon la revendication 1 ou 2, dans lequel la réaction entre le bisulfure
(V) et le 5-[(diméthylamino)méthyl]-2-furanne-méthanol est réalisée en présence d'acide
chlorhydrique.
4. Procédé selon la revendication 3, dans lequel la réaction est réalisée en présence
d'acide chlorhydrique concentré à une température initiale de 0-4°C, suivie d'un chauffage
pendant une courte période à 90―100°C.
5. Procédé selon l'une quelconque des revendications 1 à 4, dans lequel le bisulfure
(V) est préparé par réaction d'une cystamine et d'une nitroéthènamine de formule (III)
et cette réaction est réalisée en présence d'un solvant convenable.
6. Procédé selon la revendication 5, dans lequel le solvant est l'eau.
7. Procédé selon l'une quelconque des revendications 1 à 6, dans lequel on fait passer
un courant régulier de gaz à travers le réacteur pendant la préparation du bisulfure.
8. Procédé selon l'une quelconque des revendications 1 à 7, dans lequel le composé
de formule (1) est transformé en sel d'addition avec un acide.
9. Procédé selon la revendication 8, dans lequel le sel d'addition avec un acide est
le chlorhydrate.